Aside from being associated with progression-free survival of GBM patients, protein overexpression of c-MET has been significantly associated with poor overall survival of affected patients (HR = 2.761, 95 % CI = 1.214-6.280, P-value = 0.015). This evidence concerns the gene MET and glioblastoma.